Author:
Jaiswar S. P.,Gupta Amrit,Sachan Rekha,Natu S. N.,Shaili Mohan
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynaecology
Reference6 articles.
1. Qublan HS, Amarun V, Bateinen O, et al. LDH as biochemical marker of adverse pregnancy outcome in severe preeclampsia. Med Sci Monit. 2005;11:393–7.
2. He S, Bremme K, Kallner A, et al. Increased concentrations of lactate dehydrogenase in pregnancy with preeclampsia; a predictor for birth of small for gestational age infants. Gynecol Obstet Invest. 1995;39:234–8.
3. Martin JN Jr, May WL, Magann EF, et al. Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol. 1999;180:1407–14.
4. Catanzerite VA, Steinberg SM, Mosley CA, et al. Severe preeclampsia with fulminant and extreme elevation of aspartate aminotransferase and lactate dehydrogenase levels. Am J Perinatol. 1995;12:310–3.
5. Demir SC, Evruke C, Ozgunen FT, et al. Factors that influence morbidity, and mortality in severe preeclampsia, eclampsia and HELLP syndrome. Saudi Med J. 2006;27:1015–8.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献